Literature DB >> 24231406

The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.

Kyle D Fugit1, Bradley D Anderson2.   

Abstract

The use of liposomal delivery systems for the treatment of cancer has been extensively researched because of their passive targeting to the vasculature of solid tumors. While their potential to provide prolonged retention and high drug encapsulation is desirable for anticancer agents, a mechanistic understanding is required to optimize and design liposomal drug delivery systems capable of controllable release tailored to tumor type and patient. Topotecan (TPT) is a topoisomerase I inhibitor that undergoes reversible, pH-sensitive ring-opening hydrolysis. TPT may benefit from liposomal formulation using active loading strategies to generate low intravesicular pH to prolong drug retention and increase drug encapsulation. This paper develops a mathematical model to describe TPT's permeability as a function of pH by accounting for the drug's ionization state, membrane binding, and ring-opening interconversion kinetics. Studies were conducted to determine the acid dissociation constant of TPT's phenolic -OH and interconversion kinetics between TPT's lactone and carboxylate forms. Using the constants determined from these studies and release studies conducted at varying pH, permeability coefficients and membrane binding constants for each species of TPT were determined. Based on this model, three permeable species were observed. Interestingly, the two most permeable species were zwitterionic forms of TPT, and the permeability of the lactone zwitterion was comparable to that of the neutral form of another camptothecin analogue. Furthermore, release was affected by based-catalyzed interconversion kinetics between TPT's lactone and carboxylate forms. At neutral pH, release was rate-limited by formation of the TPT lactone from the ring-opened carboxylate form. Based on these findings, the developed model describing liposomal release of TPT may be used in the future to evaluate and optimize loading and subsequent release of liposomal TPT formulations utilizing active loading strategies.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kinetics; Liposomes; Membrane binding; Nanotechnology; Permeability; Topotecan

Mesh:

Substances:

Year:  2013        PMID: 24231406      PMCID: PMC4104781          DOI: 10.1016/j.jconrel.2013.11.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  54 in total

Review 1.  Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.

Authors:  Daryl C Drummond; Charles O Noble; Mark E Hayes; John W Park; Dmitri B Kirpotin
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

2.  A Rigorous Theory of Remote Loading of Drugs into Liposomes: Transmembrane Potential and Induced pH-Gradient Loading and Leakage of Liposomes

Authors: 
Journal:  J Colloid Interface Sci       Date:  1997-01-01       Impact factor: 8.128

3.  Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.

Authors:  Sweta Modi; Tian-Xiang Xiang; Bradley D Anderson
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

4.  Comparison between orientational and conformational orders in fluid lipid bilayers.

Authors:  V R Kodati; M Lafleur
Journal:  Biophys J       Date:  1993-01       Impact factor: 4.033

Review 5.  Modulation of camptothecin analogs in the treatment of cancer: a review.

Authors:  D F Kehrer; O Soepenberg; W J Loos; J Verweij; A Sparreboom
Journal:  Anticancer Drugs       Date:  2001-02       Impact factor: 2.248

6.  Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors.

Authors:  Gerald Batist; Karen A Gelmon; Kim N Chi; Wilson H Miller; Stephen K L Chia; Lawrence D Mayer; Christine E Swenson; Andrew S Janoff; Arthur C Louie
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

7.  Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.

Authors:  Euan C Ramsay; Malathi Anantha; Jason Zastre; Marieke Meijs; Jet Zonderhuis; Dita Strutt; Murray S Webb; Dawn Waterhouse; Marcel B Bally
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

8.  Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.

Authors:  Vijay Joguparthi; Bradley D Anderson
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

9.  Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.

Authors:  L D Mayer; L C Tai; M B Bally; G N Mitilenes; R S Ginsberg; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1990-06-27

10.  A 13C and 2H nuclear magnetic resonance study of phosphatidylcholine/cholesterol interactions: characterization of liquid-gel phases.

Authors:  T H Huang; C W Lee; S K Das Gupta; A Blume; R G Griffin
Journal:  Biochemistry       Date:  1993-12-07       Impact factor: 3.162

View more
  9 in total

Review 1.  Mitochondrial membrane potential.

Authors:  Ljubava D Zorova; Vasily A Popkov; Egor Y Plotnikov; Denis N Silachev; Irina B Pevzner; Stanislovas S Jankauskas; Valentina A Babenko; Savva D Zorov; Anastasia V Balakireva; Magdalena Juhaszova; Steven J Sollott; Dmitry B Zorov
Journal:  Anal Biochem       Date:  2017-07-12       Impact factor: 3.365

Review 2.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

3.  Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Authors:  Andrei Ponta; Kyle D Fugit; Bradley D Anderson; Younsoo Bae
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

4.  Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.

Authors:  Kyle D Fugit; Amar Jyoti; Meenakshi Upreti; Bradley D Anderson
Journal:  J Control Release       Date:  2014-10-25       Impact factor: 9.776

5.  In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization.

Authors:  Roger Gilabert-Oriol; Lina Chernov; Malathi Anantha; Wieslawa H Dragowska; Marcel B Bally
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

6.  An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids.

Authors:  Amar Jyoti; Kyle D Fugit; Pallavi Sethi; Ronald C McGarry; Bradley D Anderson; Meenakshi Upreti
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

7.  Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide.

Authors:  Guo-Feng Luo; Wei-Hai Chen; Yun Liu; Qi Lei; Ren-Xi Zhuo; Xian-Zheng Zhang
Journal:  Sci Rep       Date:  2014-08-14       Impact factor: 4.379

8.  Is the Mitochondrial Membrane Potential (∆Ψ) Correctly Assessed? Intracellular and Intramitochondrial Modifications of the ∆Ψ Probe, Rhodamine 123.

Authors:  Ljubava D Zorova; Evgeniya A Demchenko; Galina A Korshunova; Vadim N Tashlitsky; Savva D Zorov; Nadezda V Andrianova; Vasily A Popkov; Valentina A Babenko; Irina B Pevzner; Denis N Silachev; Egor Y Plotnikov; Dmitry B Zorov
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

9.  Dynamic, nonsink method for the simultaneous determination of drug permeability and binding coefficients in liposomes.

Authors:  Kyle D Fugit; Bradley D Anderson
Journal:  Mol Pharm       Date:  2014-03-28       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.